SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-006474
Filing Date
2017-02-03
Accepted
2017-02-03 17:17:02
Documents
5
Period of Report
2017-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-3751_18k.htm 8-K 40749
2 EX-4.1 a17-3751_1ex4d1.htm EX-4.1 135197
3 EX-99.1 a17-3751_1ex99d1.htm EX-99.1 12021
4 GRAPHIC g37511kg01i001.gif GRAPHIC 1488
5 GRAPHIC g37511mmi001.jpg GRAPHIC 3455
  Complete submission text file 0001104659-17-006474.txt   196626
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 17573071
SIC: 2834 Pharmaceutical Preparations